JP2023542701A5 - - Google Patents
Info
- Publication number
- JP2023542701A5 JP2023542701A5 JP2023519000A JP2023519000A JP2023542701A5 JP 2023542701 A5 JP2023542701 A5 JP 2023542701A5 JP 2023519000 A JP2023519000 A JP 2023519000A JP 2023519000 A JP2023519000 A JP 2023519000A JP 2023542701 A5 JP2023542701 A5 JP 2023542701A5
- Authority
- JP
- Japan
- Prior art keywords
- mitapibat
- approximately
- amount
- composition according
- child
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063083834P | 2020-09-25 | 2020-09-25 | |
| US63/083,834 | 2020-09-25 | ||
| US202063107196P | 2020-10-29 | 2020-10-29 | |
| US63/107,196 | 2020-10-29 | ||
| US202163238483P | 2021-08-30 | 2021-08-30 | |
| US63/238,483 | 2021-08-30 | ||
| PCT/US2021/051957 WO2022067039A1 (en) | 2020-09-25 | 2021-09-24 | Pharmaceutical formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542701A JP2023542701A (ja) | 2023-10-11 |
| JP2023542701A5 true JP2023542701A5 (https=) | 2024-10-01 |
Family
ID=78179552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519000A Pending JP2023542701A (ja) | 2020-09-25 | 2021-09-24 | 薬学的製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230338283A1 (https=) |
| EP (1) | EP4216956A1 (https=) |
| JP (1) | JP2023542701A (https=) |
| KR (1) | KR20230074536A (https=) |
| AU (1) | AU2021347349A1 (https=) |
| CA (1) | CA3196829A1 (https=) |
| IL (1) | IL301596A (https=) |
| MX (1) | MX2023003431A (https=) |
| TW (1) | TW202228691A (https=) |
| WO (1) | WO2022067039A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI598337B (zh) | 2009-06-29 | 2017-09-11 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| CA2989111C (en) | 2015-06-11 | 2023-10-03 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
| KR102777452B1 (ko) | 2017-11-22 | 2025-03-10 | 아지오스 파마슈티컬스 아이엔씨. | N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의결정 형태 |
-
2021
- 2021-09-24 EP EP21791565.1A patent/EP4216956A1/en active Pending
- 2021-09-24 AU AU2021347349A patent/AU2021347349A1/en active Pending
- 2021-09-24 MX MX2023003431A patent/MX2023003431A/es unknown
- 2021-09-24 TW TW110135559A patent/TW202228691A/zh unknown
- 2021-09-24 JP JP2023519000A patent/JP2023542701A/ja active Pending
- 2021-09-24 WO PCT/US2021/051957 patent/WO2022067039A1/en not_active Ceased
- 2021-09-24 US US18/028,058 patent/US20230338283A1/en active Pending
- 2021-09-24 KR KR1020237013787A patent/KR20230074536A/ko active Pending
- 2021-09-24 IL IL301596A patent/IL301596A/en unknown
- 2021-09-24 CA CA3196829A patent/CA3196829A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI335217B (en) | Pharmaceutical formulations of modafinil | |
| JP6491174B2 (ja) | ニタゾキサニドの制御放出医薬配合物 | |
| EP2317997B1 (en) | Low dose topiramate/phentermine compostion and methods of use thereof | |
| US20040029941A1 (en) | Zonisamide use in obesity and eating disorders | |
| US20110081385A1 (en) | Compositions and Methods for Sleep Regulation | |
| ES2762113T3 (es) | Métodos de proporcionar terapia de pérdida de peso en pacientes con depresión mayor | |
| JPH0635382B2 (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| JP3841846B2 (ja) | 過血糖症を治療するための薬剤学的製剤 | |
| JP2004525940A (ja) | 火照りの処置のためのデュロキセチン | |
| NO20001717L (no) | Serotonin-inneholdende formulering for oral administrering og anvendelse av samme | |
| EP1496868A1 (en) | Controlled release pharmaceutical compositions of carbidopa and levodopa | |
| JP2023542701A5 (https=) | ||
| US20240100011A1 (en) | Pediatric formulations of ferric citrate | |
| CN101175477A (zh) | 碘塞罗宁的控释药物组合物及其制备和使用方法 | |
| Serafini et al. | The use of rotigotine in the treatment of restless legs syndrome | |
| JP2025501922A5 (https=) | ||
| JP4384435B2 (ja) | くしゃみ抑制組成物 | |
| JP2004532866A (ja) | ２型インスリン抵抗性真性糖尿病患者の治療のためのビオチンと組合せてのアセチルｌ−カルニチンの使用 | |
| KR101362679B1 (ko) | 프랄나카산의 지연 방출 제형 | |
| CN110913843A (zh) | 药物组合物 | |
| WO2024155828A1 (en) | Uses of aminopyridines in the management of weight and satiety | |
| WO2022234408A1 (en) | Alpelisib formulation | |
| US20080299189A1 (en) | Controlled release dopamine agonist compositions | |
| JP2023553354A5 (https=) |